๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions

โœ Scribed by Shahla Masood

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
547 KB
Volume
8
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Estrogen and progesterone receptors in m
Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary
โœ John P. Geisler; Michael C. Wiemann; Greg A. Miller; Zhen Zhou; Hans E. Geisler ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 302 KB

Malignant mixed mesodermal tumors of the ovary occur in less than 1% of cases of ovarian cancer. They have a dismal prognosis and the most effective type of therapy is still not known. All cases of malignant mixed mesodermal tumor of the ovary between January 1, 1985 and May 1, 1994 operated on by t

Expression of receptors for estrogen and
Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival
โœ Kaklamanos, Ioannis G.; Bathe, Oliver F.; Franceschi, Dido; Lazaris, Andreas Ch. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 2 views

Background and Objectives: Estrogen receptors (ER) and progesterone receptors (PR) have been detected in both normal and malignant colonic mucosa, but the prognostic value of this observation is unknown. We aimed to define the prognostic significance of the presence of ER and PR in malignant cells f

Evaluation of new monoclonal antibodies
Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis
โœ K. Z. Hanley; M. T. Siddiqui; D. Lawson; C. Cohen; A. Nassar ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 372 KB ๐Ÿ‘ 1 views

## Abstract Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Her2 status of breast carcinomas is critical for predicting response to systemic therapies. Recently, developed rabbit monoclonal antibodies (RMab) are reported to have higher sensitivity than murine monoclon